Insider · CIK 0001703090

Lang James Paul

Reports to the SEC for 3 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001703090

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	OPRXOptimizeRx CorpA Award	Director	AAward	+34.5K sh	—	—	433,837
2026-05-05	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+3,796 sh	—	—	4,685
2026-05-05	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	Director	AAward	+6,040 sh	—	—	6,040
2026-01-05	BIVIBIOVIE INC. · Stock Option (right to buy)A Award	Director	AAward	+90K sh	—	—	90,000
2026-01-05	BIVIBIOVIE INC. · Stock Option (right to buy)A Award	Director	AAward	+331K sh	—	—	330,500
2026-01-02	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+889 sh	—	—	889
2026-01-02	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	Director	AAward	+1,342 sh	—	—	1,342
2025-06-11	OPRXOptimizeRx CorpA Award	Director	AAward	+9,868 sh	—	—	399,320
2025-03-14	OPRXOptimizeRx CorpP Purchase	Director	PPurchase	+321K sh	$7.60	+$2.44M	389,452
2024-12-20	BIVIBIOVIE INC. · Stock Option (right to buy)A Award	Director	AAward	+22.7K sh	—	—	22,690
2024-11-20	BIVIBIOVIE INC. · Stock Option (right to buy)A Award	Director	AAward	+61.6K sh	—	—	61,600
2024-06-07	OPRXOptimizeRx CorpA Award	Director	AAward	+13.3K sh	—	—	68,044
2024-06-05	OPRXOptimizeRx CorpM Exercise/Conversion	Director	MExercise/Conversion	+10.1K sh	—	—	54,758
2024-06-05	OPRXOptimizeRx Corp · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−10.1K sh	—	—	0
2023-11-09	BIVIBIOVIE INC. · Stock Option (right to buy)A Award	Director	AAward	+93.5K sh	—	—	93,500
2023-06-07	OPRXOptimizeRx CorpM Exercise/Conversion	Director	MExercise/Conversion	+4,637 sh	—	—	44,697
2023-06-07	OPRXOptimizeRx Corp · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,637 sh	—	—	0
2023-06-07	OPRXOptimizeRx Corp · Restricted Stock UnitsA Award	Director	AAward	+10.1K sh	—	—	10,061
2023-03-30	OPRXOptimizeRx CorpM Exercise/Conversion	Director	MExercise/Conversion	+657 sh	—	—	40,060
2023-03-30	OPRXOptimizeRx Corp · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−657 sh	—	—	657
2022-12-30	OPRXOptimizeRx CorpM Exercise/Conversion	Director	MExercise/Conversion	+409 sh	—	—	39,403
2022-12-30	OPRXOptimizeRx Corp · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−409 sh	—	—	0
2022-11-23	BIVIBIOVIE INC.A Award	Director	AAward	+43.6K sh	—	—	68,622
2022-09-29	OPRXOptimizeRx CorpM Exercise/Conversion	Director	MExercise/Conversion	+334 sh	—	—	38,994
2022-09-29	OPRXOptimizeRx Corp · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−334 sh	—	—	0
2022-08-19	OPRXOptimizeRx CorpP Purchase	Director	PPurchase	+6,000 sh	$16.45	+$98.7K	38,660
2022-06-09	OPRXOptimizeRx Corp · Restricted Stock UnitsA Award	Director	AAward	+4,637 sh	—	—	4,637
2022-04-05	BIVIBIOVIE INC. · Stock Option (right to buy)A Award	Director	AAward	+128K sh	—	—	127,900
2022-03-30	OPRXOptimizeRx Corp · Restricted Stock UnitsA Award	Director	AAward	+657 sh	—	—	657
2021-12-30	OPRXOptimizeRx Corp · Restricted Stock UnitsA Award	Director	AAward	+409 sh	—	—	743
2021-09-29	OPRXOptimizeRx Corp · Restricted Stock UnitsA Award	Director	AAward	+334 sh	—	—	334
2021-06-30	OPRXOptimizeRx CorpA Award	Director	AAward	+407 sh	—	—	32,660
2021-03-31	OPRXOptimizeRx CorpA Award	Director	AAward	+539 sh	—	—	32,253
2020-12-31	OPRXOptimizeRx CorpA Award	Director	AAward	+802 sh	—	—	31,714
2020-12-18	BIVIBIOVIE INC. · optionsA Award	Director	AAward	+99K sh	$13.91	+$1.38M	120,988
2020-09-30	OPRXOptimizeRx CorpA Award	Director	AAward	+1,183 sh	—	—	30,912
2020-06-30	OPRXOptimizeRx CorpA Award	Director	AAward	+1,937 sh	—	—	29,729
2020-03-30	OPRXOptimizeRx CorpA Award	Director	AAward	+2,784 sh	—	—	27,792
2020-01-19	BIVIBIOVIE INC. · optionsA Award	Director	AAward	+800 sh	$2.80	+$2,240	21,988
2020-01-03	OPRXOptimizeRx CorpA Award	Director	AAward	+2,084 sh	—	—	25,008
2020-01-02	BIVIBIOVIE INC.A Award	Director	AAward	+1,600 sh	$3.50	+$5,600	25,044
2019-09-30	OPRXOptimizeRx CorpA Award	Director	AAward	+2,084 sh	—	—	22,924
2019-03-29	OPRXOptimizeRx CorpA Award	Director	AAward	+2,084 sh	—	—	14,585
2019-01-19	BIVIBIOVIE INC. · optionsA Award	Director	AAward	+800 sh	$3.75	+$3,000	21,188
2019-01-02	BIVIBIOVIE INC.A Award	Director	AAward	+200K sh	$0.04	+$7,000	450,000
2018-10-08	OPRXOptimizeRx CorpA Award	Director	AAward	+2,084 sh	—	—	12,501
2018-07-03	BIVIBIOVIE INC.A Award	Director	AAward	+20K sh	$1.50	+$30K	20,000
2018-07-02	BIVIBIOVIE INC. · WarrantsA Award	Director	AAward	+2M sh	$0.02	+$36K	2,548,485
2018-06-29	OPRXOptimizeRx CorpA Award	Director	AAward	+2,084 sh	—	—	10,417
2018-01-19	BIVIBIOVIE INC. · optionsA Award	Director	AAward	+100K sh	$0.10	+$10K	548,485

Recent filings

Accepted (ET)
Jun 104
Lang James Paul0001628280-26-042132
SEC(opens sec.gov)
May 74
Lang James Paul0001159036-26-000062
SEC(opens sec.gov)
Jan 94
Lang James Paul0001520138-26-000017
SEC(opens sec.gov)
Jan 64
Lang James Paul0001159036-26-000007
SEC(opens sec.gov)
Jun 124
Lang James Paul0001628280-25-031022
SEC(opens sec.gov)
Mar 194
Lang James Paul0001628280-25-013918
SEC(opens sec.gov)
Jan 74
Lang James Paul0001520138-25-000020
SEC(opens sec.gov)
Jun 114
Lang James Paul0001628280-24-027709
SEC(opens sec.gov)
Dec 64
Lang James Paul0001520138-23-000535
SEC(opens sec.gov)
Aug 184
Lang James Paul0001628280-23-029928
SEC(opens sec.gov)
Apr 34
Lang James Paul0001628280-23-010323
SEC(opens sec.gov)

Companies

Address

C/O OPTIMIZERX CORPORATION 260 CHARLES STREET, SUITE 302

WALTHAM, MA, 02453